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Abstract
Background: Many clinical studies have demonstrated that early postoperative enteral nutrition
(EN) improved the postroperative course. Post-pancreaticoduodenectomy (PD), patients tend to
suffer from postoperative nausea, abdominal distention, and diarrhoea, causing difficulty in the
introduction of EN. In this pilot study, we investigated the appropriate nutritional mode post-
pancreatic surgery.
Methods: Between October 2006 and March 2007 2 postoperative nutritional methods were
implemented in 17 patients in a prospective single-centere study. Eight patients received only
enteral nutrition (EN group) and 9 patients received enteral nutrition combined with parenteral
nutrition (EN + PN group).
Results: There were no differences in the patient characteristics and postoperative morbidity
between the 2 groups. The rate of discontinuance of enteral feeding was significantly high in the EN
group, and the duration of enteral feeding was significantly longer in the EN + PN group. The
central venous line was retained for a significantly longer period in the EN + PN group, but there
was no difference in the frequency of catheter-related infection between the 2 groups.
Conclusion: EN combined with PN is more adequate for patients after pancreatic surgery.
Background
In current digestive surgical practice, the benefits of
enteral nutritional support, in comparison with
parenteral nutrition, are widely recognized. Recent experi-
ences have shown that early postoperative enteral nutri-
tion (EN) enhanced immunocompetence, reduced
clinical infection rates, and maintained gut structure and
function, and it can potentially attenuate catabolic stress
responses in patients after surgery [1-5]. Although many
studies have reported that catheter-associated infective
complications are more frequently elicited by total
parenteral nutrition (TPN), some studies have reported
that the TPN-associated infections can be attributed to
hyperglycemia and caloric overload, and that insulin ther-
Published: 11 June 2009
Nutrition Journal 2009, 8:24 doi:10.1186/1475-2891-8-24
Received: 4 November 2008
Accepted: 11 June 2009
This article is available from: http://www.nutritionj.com/content/8/1/24
© 2009 Nagata et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
Page 2 of 8
(page number not for citation purposes)
apy can alleviate these infections [6,7]. In addition,
enteral nutrition is believed be safer and less expensive
than parenteral nutrition. However, postoperative total
enteral feeding is associated with complications such as
diarrhoea, abdominal distention, and abdominal cramps.
On the basis of our experience and the findings of previ-
ous studies [8,9], we believed that these symptoms wors-
ened with increasing caloric intake and finally lead to
discontinuance of enteral feeding.
Pancreaticoduodenectomy (PD) is associated with a high
incidence of postoperative complications, even when the
procedure is performed at high-volume centers. An overall
morbidity rate of 48% can be anticipated at major centers,
while the mortality rate in these centers is less than 4%.
The high rate of complications can delay postoperative
resumption of adequate oral food intake. Moreover, can-
cer or chronic pancreatitis patients who are candidates for
PD often have associated comorbidities such as diabetes,
jaundice, and protein-energy malnutrition [9,10]. Taken
together, these issues present the case for artificial nutri-
tional support. However, there is very limited clinical data
on postoperative feeding after major pancreatic resections
[8-10]. Therefore, we believe that the optimal nutritional
method after pancreatic surgery has still not been identi-
fied.
In our institution, which is a high-volume center for pan-
creatic surgery, the patients who underwent PD, including
pylorus-preserved PD (PpPD), routinely received enteral
feeding from the early postsurgical period. However, there
was no clinical regimen for enteral nutrition, and the
menu for enteral feeding, which was prescribed by the
doctors, was unique for each patient. We retrospectively
examined 30 patients who underwent PD and PpPD in
the 18 months prior to this study. It was observed that
enteral feeding was discontinued and changed to TPN in
many of these patients because of diarrhoea and abdomi-
nal distention.
In this prospective pilot study, we aimed to identify the
ideal post-PD nutritional mode that could be adminis-
tered without any interruptions and we compared the
clinical outcomes, nutritional status, and immunological
status of the 2 modes of postoperative nutrition, namely,
enteral nutrition and enteral nutrition combined with
parenteral nutrition.
Methods
Patients
We prospectively investigated 17 patients (12 men and 5
women; mean age, 68.3 years; range, 43–86 years) who
had undergone PD or PpPD for peri-ampullary tumors
between October 2006 and March 2007 at the Oita Red
Cross Hospital. Among these 17 patients, there were 10
cases of pancreatic invasive ductal carcinoma, 5 cases of
cholangiocarcinoma, and 2 cases of chronic pancreatitis
with inflammatory mass (Table 1). The exclusion criteria
included clinically relevant organ failure, ongoing infec-
tions, and inflammatory bowel diseases. Fully informed
consent was obtained from all the patients. After surgery,
randomization was performed using sealed envelopes.
The patients were divided into 2 groups: those who
received only enteral nutrition (EN group, n = 8) and
those who received both enteral and parenteral nutrition
(EN + PN group, n = 9).
Surgical procedure
The standard PD consisted of distal gastrectomy encom-
passing the duodenum and common bile duct, the gall-
bladder, and the head, neck, and the uncinate process of
the pancreas; lymphadenectomy was also performed.
Standard lymph-node dissection was performed accord-
ing to the definition provided by Pedrazzoli et al. [11]. In
PpPD, the duodenum was divided at a point 2 cm away
from the pylorus. The passage was reconstructed by pan-
creatogastrostomy, end-to-side hepaticojejunostomy,
end-to-end gastrojejunostomy in PD or pylorojejunos-
tomy in PpPD, and an end-to-side jejunojejunostomy
Table 1: Postoperative complications
Complication EN group
(n = 8)
EN+PN group
(n = 9)
Surgery related complications
Pancreatic leakage (minor leakage) 0 1
Anastomotic leakage (minor leakage) 1 0
Ileus 10
Ulcer at anastomotic portion 0 1
Wound infection 31
General complications
Pulmonary 10
Total number of patients with complications 5 4
Mortality 10
No significant differences noted.Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
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using the Roux-en-Y-technique (30 cm aborally from the
gastrojejunal anastomosis). For postoperative nutritional
support, all the patients received needle-catheter jejunos-
tomy at the end of the operation Then, 8-Fr silicone jeju-
nal tubes were inserted from the proximal portion of the
jejunojejunostomy and fixed by the modified Witzel tech-
nique. The opposite tip was extracorporeally induced via
an abdominal wall at the left flank.
Postoperative nutrition
All the patients in both the groups received enteral feeding
with/without parenteral nutrition as per the schedule out-
lined in Fig. 1. Briefly, the infusion of 500 ml of 5% glu-
cose commenced within 12 h after surgery, and enteral
feeding was started on postoperative day (POD) 2 in both
the groups. All the patients in the 2 groups reached the
maximum value of total caloric intake (obtained by Har-
ris-Benedict equation) on POD 4. In the EN group, total
caloric intake was 600 kcal/day on POD 2 and 1000 kcal/
day on POD 3, supplemented with peripheral parenteral
nutrition (PPN). In the EN + PN group, EN was started at
200 kcal/day and increased every 2 days to a maximum
value of 600 kcal/day. The patients in the EN + PN group
received parenteral nutrition by PPN and TPN to compen-
sate for the caloric shortage. Parenteral nuturition was
preferentially decreased. Oral intake was started on POD
7. TPN was stopped when the oral intake was over 500
kcal/day, and EN was stopped when the oral intake was
over 1000 kcal/day. A unified enteral diet (Isocal; Mead
Johnson, Evansville, IN) containing 1000 kcal, 33 g pro-
tein, 123 g carbohydrates, and 42 g lipids per liter was
administered to the patients. Possible adverse reactions to
enteral nutrition were recorded daily. Enteral feeding was
reduced or discontinued in case of intolerable emesis,
abdominal distention/cramps, or diarrhoea.
Catheter regimen
A central venous catheter was preoperatively inserted in
all the patients; gabexate mesilate 1.5 g/24 h (FOY; Ono,
Osaka, Japan) was administered through the catheter for
3 days after the operation. During the operation, all the
patients received intra-abdominal drainage and urinary
catheter. These catheters were removed as soon as possi-
ble, except in 1 case that had serious complications.
Laboratory and clinical investigations
The operation time, blood-loss volume, and amount of
blood transfusion during and after the surgery were care-
fully recorded. The samples for laboratory investigations
were obtained on PODs 1, 3, 5, 7, and 14. The laboratory
parameters assessed included the serum levels of total
protein, albumin, pre-albumin, and transferrin (as nutri-
tional parameters); lymphocyte counts, T-cell subpopula-
tion (the ratio of CD4 T cells to CD8 T cells, i.e. CD4/
CD8), and serum levels of IgG, IgM, and IgA (as immuno-
logical parameters); and the serum levels of total
bilirubin, cholinesterase, alanine transaminase, aspartate
transaminase, lactate dehydrogenase, alkaline phos-
patase, gamma-glutamyl transpeptidase, amylase, urea
nitrogen, and creatinine (as biochemical parameters).
Body weight was periodically measured before and after
the surgery. Postoperative complications, including surgi-
cal-site infection, leakage from anastomose, pancreatic fis-
tula, cholangitis, small-bowel obstruction, delayed gastric
emptying (a surgery-related complication), abdominal
cramps, distention, diarrhea, and vomiting (an enteral-
feeding-related complication) were carefully monitored
every day.
Statistical analysis
The data are expressed as means ± SEM. The statistical sig-
nificance of the data was determined by unpaired and
paired Student's t tests or the chi-square test. P values <
0.05 were considered to be statistically significant. Statis-
tical calculations were performed using Prism Version 4.0
(GraphPad Software Inc.).
Schedules of postoperative nutrition Figure 1
Schedules of postoperative nutrition. The infusion of 
500 ml of 5% liquid glucose commenced within 12 h of sur-
gery and enteral feeding was started on POD 2 in both 
groups. All patients in both groups reached the maximum 
volume of total caloric intake (derived using Harris-Benedict 
equation), on POD 4. In the EN group, the total volume of 
EN was 600 kcal/day on POD 2 and 1000 kcal/day on POD 3 
with PPN. In the EN + PN group, EN started at 200 kcal/day 
and was increased every 2 days to a maximum volume of 600 
kcal/day from POD 6. The patients received PPN until POD 
3 or TPN from POD 4 to compensate for the caloric short-
age. Oral intake started on POD 7. TPN was stopped when 
oral intake was over 500 kcal/day and enteral nutrition was 
stopped when oral intake was over 1000 kcal/day. EN: 
enteral nutrition, PPN: peripheral parenteral nutrition, TPN: 
total parenteral nutrition, OI: oral intake.Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
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Results
A total of 17 patients were enrolled in this study. The
median age of the subjects was 68 years (range, 43–86
years). Eight patients received postoperative nutritional
support primarily by enteral nutrition (EN group), and 9
patients received postoperative nutritional support in the
form of enteral feeding combined with parenteral nutri-
tion (EN + PN group). Both groups were comparable with
respect to patient characteristics, preoperative factors, and
preoperative laboratory findings (Table 2). With respect to
intraoperative factors, there were no significant differ-
ences between the 2 groups in any of the parameters,
including operation time, blood loss, number of patients
who received blood transfusion, surgical procedure, and
histopathological diagnosis (Table 3).
The overall postoperative morbidity across all the study
groups was 53%, and this value did not differ between the
2 groups (Table 1). One patient in the EN + PN group
reported with minor pancreatic leakage. Another patient
in the EN group reported with minor leakage of the gas-
trojejunal anastomosis. They conservatively recovered
without any treatment. Another patient in the EN group
died as a result of acute respiratory distress syndrome
caused by infection. There were no differences in other
complications, including ileus, anastomotic ulcer, and
surgical-site infection, between the 2 groups. The overall
mortality was 5.8%.
Although the methods used for postoperative nutrition
were different in each group, the total caloric intake in the
2 groups, including the caloric intake attributed to
EN+PN, was similar (Fig. 1).
With respect to the factors related to postoperative nutri-
tion, enteral feeding was well tolerated in the patients of
the EN + PN group, and few patients exhibited symptoms.
In 1 patient (11.1%) in the EN + PN group, enteral feeding
was discontinued due to diarrhea before resumption of
oral intake. In contrast, in the EN group, enteral feeding
was discontinued before resuming oral intake or sufficient
oral intake in 5 of the 8 patients (62.5%), primarily due to
diarrhea and abdominal distention (Table 4). Further-
more, the duration of enteral feeding in the EN group was
significantly shorter than that in the EN + PN group (10.6
± 2.3 days vs. 23.5 ± 4.4 days, p = 0.0255). However, the
duration of retention of the central venous line in the EN
+ PN group was significantly longer than that in the EN
group (7.7 ± 1.1 days vs. 12.0 ± 1.5 days, p = 0.0418).
However, there were no significant differences in the fre-
quency of catheter-related infections between the 2
groups (Table 4). We did not observe any aspiration epi-
sodes or enteral-feeding-associated intestinal ischemia.
The percentages of weight loss on POD 21 and the lengths
of postoperative stay were not different between the 2
groups.
The subanalysis comprised 14 patients (EN group, 6; EN
+ PN group, 8), after excluding the 2 EN patients and 1 EN
+ PN patients, in whom enteral feeding could not be con-
tinued until POD 5. Among the nutritional parameters,
the levels of serum albumin, total protein, albumin, and
rapid-turn-over proteins such as pre-albumin and trans-
ferrin decreased until POD 3 and increased gradually
thereafter, but there was no significant difference between
the 2 groups (Fig. 2). Among the immunological parame-
ters, there was no significant difference in the lymphocyte
counts and the T-cell subpopulation, i.e. CD4/CD8,
between the 2 groups (data not shown). The immu-
noglobulin levels decreased in the early postoperative
days and gradually increased in the late postoperative
days, especially in the EN + PN group; at POD 14, there
were significant differences between the levels of IgA and
IgM in the 2 groups (Fig. 3). Among other biochemical
parameters, the levels of ALT were significantly reduced in
the EN group on PODs 7 and 14 (Fig. 4). The levels of ChE
decreased in the early PODs, especially in the EN + PN
group, with significant differences on PODs 1, 3, and 5
Table 2: Preoperative patient characteristics
Characteristic EN group
(n = 8)
EN+PN group
(n = 9)
Age (yr) 66.5 ± 4.8 69.8 ± 3.3
Sex (Male/female) 6/2 6/3
Body weight (kg) 61.3 ± 2.9 55.8 ± 2.2
Body mass index (m2) 24.2 ± 1.2 21.9 ± 0.5
Patients with jaundice (%) 25.0 33.3
Patients with diabetes (%) 25.0 11.1
Patients with preoperative PTCD (%) 25.0 22.2
Preoperative laboratory values
Hemoglobin (g/L) 12.9 ± 0.6 11.7 ± 0.6
Albumin (g/L) 3.6 ± 0.1 3.5 ± 0.1
Bilirubin (mg/dL) 0.9 ± 0.1 0.8 ± 0.1
No significant differences noted.
Table 3: Intraoperative factors and histopathology
Characteristic EN group
(n = 8)
EN+PN group
(n = 9)
Duration of surgery (min) 457.4 ± 18.6 564.6 ± 56.6
Operative blood loss (mL) 954.3 ± 155.5 954.4 ± 271.3
Blood transfusion (%) 62.5 77.7
Surgical Procedures (PD/PpPD) 2/6 6/3
Histopathologic finding
Pancreatic carcinoma 6 7
Cholangio cellular carcinoma 1 1
Chronic pancreatitis 1 1
No significant differences noted.Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
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(Fig. 4). On PODs 5 and 7, the levels of lactate were sig-
nificantly low in the EN + PN group (Fig. 4).
Discussion
PD is associated with a high incidence of postoperative
complications even when performed at a high-volume
center. While the mortality rate can be reduced to less than
4%, the incidence of postoperative complications contin-
ues to range from 35% to 50% in most series. Most
patients with pancreatic tumors present with significant
weight loss due to anorexia and malabsorption, and they
may to undergo a period of inadequate oral intake for up
to 10 days after surgery [9,10].
In the last decade, several clinical and experimental stud-
ies have reported on the beneficial effects of perioperative
enteral nutrition, especially early postoperative enteral
feeding, over parenteral and delayed enteral nutrition
under critical conditions [1-5]. While the precise mecha-
nisms through which early enteral feeding exerts its posi-
Table 4: Factors related postoperative nutrition
EN group
(n = 8)
EN+PN group
(n = 9)
P value
Nutrition related complications
Dirrhea 6 4 0.2014
Abdominal distention 7 1 0.0016
Nausea 2 3 0.7066
Removal day of central venous catheter (POD) 7.7 ± 1.1 12.0 ± 1.5 0.0418
Frequency of catheter fever (%) 37.5 22.2 0.4902
Duration of Enteral nutrition (days) 10.6 ± 2.3 23.5 ± 4.4 0.0255
Drop-out rate of EN (%) 62.5 11.1 0.0269
First day of oral intake (POD) 8.8 ± 0.9 8.4 ± 1.2 0.8068
Weght loss ratio on POD 21 (%) 12.9 ± 2.2 12.3 ± 1.7 0.8393
Hospital stay (days) 40.4 ± 5.9 57.2 ± 4.0 0.0826
Comparison of nutritional parameters Figure 2
Comparison of nutritional parameters. Mean values of prealbumin and transferrin in the EN (square) and EN + PN (trian-
gle) groups. The error bars represent the standard error of the mean (SEM).Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
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tive actions on the outcome are still unclear, the
preservation of the integrity of gut structure/function, bal-
anced intestinal microflora, and the maintenance of an
effective local and systemic immunocompetence, have
been strongly implicated [1-5,8]. Despite these theoretical
and clinical advantages, many surgeons remain commit-
ted to a postoperative period of "bowel rest", which has
long been hypothesized, but never demonstrated to
reduce the risk of anastomotic leak. The role of artificial
nutrition in affecting morbidity after major pancreatic
resection has been markedly neglected. In 1994, Brennan
et al. published the first trial on postoperative nutritional
support in patients undergoing PD, and they reported that
routine postoperative TPN could not be recommended
[12]. Since then, many reports have indicated the effect of
postoperative enteral nutrition after PD [9,10].
In our unit, which is a high-volume centre of pancreatic
surgery, all patients received enteral feeding after surgery.
However, there was no guideline for postoperative nutri-
tional support in our unit. Before performing this study,
we retrospectively examined the nutritional aspects and
postoperateive complaications of 30 patients who under-
went PD, including PpPD (not published). In the data
obtained from these examinations, the ratio of enteral
nutrition drop-outs was high (34.6%), which could be
primarily attributed to diarrhea in the early postoperative
period, although previous studies reported that approxi-
Comparison of immunological parameters Figure 3
Comparison of immunological parameters. Mean values of IgG, IgM, and IgA in the EN (square) and EN + PN (triangle) 
groups. The error bars represent the SEM; * signifies p < 0.05.Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
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mately 90% of the enterally fed patients reached the full
nutritional regimen within 4 days after digestive surgeries,
such as esophageal resection and gastrointestinal resec-
tion [1-5]. We considered that in PD procedure encom-
passing the lymph node and/or including ganglion
dissection around the celiac artery and the superior
mesenteric artery, diarrhoea is a frequent complication. In
addition, in our previous studies, there were no significant
differences in the nutritional and immunological param-
eters and the clinical outcomes due to the volume of
enteral feeding. Since the volume of enteral feeding was
unstable and insufficient, almost all patients tended to
undergo prolonged central venous line replacement
(median, 14.0 days; range, 5–21 days); consequently, a
number of patients showed catheter fever (30.8%). In a
recent investigation, it was revealed that the high occur-
rence of infection-related complications did not result
from the route of nutrition (total parenteral nutrition),
but was caused by hyperglycemia [6]. Strict blood-glucose
control with insulin could lead to the prevention of infec-
tious complications [7]. On the basis of these findings, we
considered enteral nutrition combined with parenteral
nutrition as a better mode of postoperative nutritional
support.
In this clinical pilot study, we primarily aimed to deter-
mine the ideal procedure of postoperative nutritional sup-
port that would ensure that the patients who underwent
PD received sufficient caloric intake without dropping
out. In the previous studies, gastrointestinal complica-
tions were observed in an unexpectedly high proportion
of the patients who received a standard enteral prepara-
tion; these complications commonly consisted of nausea,
vomiting, abdominal distension, and diarrhea [4,8-10].
Moreover, in several recent postoperative studies on
selected patients with esophageal, gastrointestinal, and
pancreatic diseases, there has been considerable variation
in the results describing the tolerance to enteral feedings
[1,3-5,8-10,12]. In these studies, enteral feeding was con-
sidered to have been successfully established in more than
70% of the patients. More than 80% of the patients
received >600 kcal/day from a standard enteral diet.
Almost all that patients achieved a feeding rate of >40 ml/
hour. On the basis of these data, we set 600 kcal/day as the
maximal dose of enteral feeding in the EN + PN group,
and we selected Isocal, which contains sufficient dietary
fiber and medium-chain fatty acids, both of which con-
tributed to the reduction in the occurrence of diarrhea as
the enteral diet in this study.
We divided the 17 patients into 2 groups according to the
mode of postoperative nutritional support: the EN and
EN + PN groups. There were no significant differences
between the baseline profiles of the 2 groups. Although
the routes of administration of the diet were different, the
patients of both groups had a similar total caloric intake,
and there was no significant difference between the nutri-
tional analysis in the 2 groups. Consistent with these find-
ings, there was no difference between the 2 groups in
terms of weight loss on POD 21. The number of patients
PD was more in the EN + PN group, while the number of
patients who underwent PpPD was more in the EN group.
However, we did not consider that this factor would cause
any bias in the evaluation of postoperative nutrition,
Comparison of biochemical parameters Figure 4
Comparison of biochemical parameters. Mean values of ALT, lactate, and ChE in the EN (square) and EN + PN (triangle) 
groups. The error bars represent the SEM; * signifies p < 0.05.Nutrition Journal 2009, 8:24 http://www.nutritionj.com/content/8/1/24
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because the jejunal tubes were inserted from the aboral
portion of the gastrojejunal anastomosis (i.e. the enteral
diet did not pass through the preserved stomach).
In the subanalysis of immunological function, there were
no significant differences in the parameters indicating cel-
lular immunity, i.e. leukocytes and lymphocytes counts
and the T cell subpopulation. Serum immunoglobulin
plays an important role in host humoral immunity.
Although the serum levels of IgA and IgM dropped
remarkably in all the patients after the operation, they
recovered quickly in the EN + PN group and were signifi-
cantly higher than those in the EN group. However,
because of the small number of patients in the present
study, it is unclear whether this findings suggests an
improvement in the postoperative immunological status.
However, there was not inflammation or infection in the
patients in the EN + PN group.
In the subanalysis of biochemical parameters, there were
no significant differences in any of the parameters, exclud-
ing those of hepatic function, between the 2 groups. The
postoperative increase in ALT and lactate levels and
decrease in the ChE level in the EN +PN group could not
be clarified. However, we considered that these changes
were caused by TPN, since it has been reported that
patients receiving TPN usually show mild-to-moderate
elevations in transaminase and alkaline phosphatase lev-
els and hepatic steatosis or portal triaditis on biopsy; the
steatosis is reversible, if TPN is administered for a short
period [13,14].
Clinically, our most suggestive finding was that more
patients of the EN group dropped out of enteral feeding,
mainly due to diarrhea and abdominal distention. The
patients of the EN + PN group received parenteral nutri-
tion for a longer duraton than the EN group (7.7 ± 1.1
days vs. 12.0 ± 1.5 days, p = 0.0418); however, it was also
demonstrated that there was no significant difference in
the occurrence of catheter-associated infections (3/8 in
the EN group vs. 2/9 in the EN + PN group, p = 0.4902)
under conditions where the central venous route was
removed as early as possible.
We suggest that enteral feeding combined with parenteral
nutrition may be as safe as total enteral nutrition, which
has been reported as the standard method, for ensuring
proper completion of postoperative nutrition. Moreover,
EN + PN can be a more suitable mode of postoperative
nutrition for the patients who have undergone PD. We
discontinued our study because many patients in the EN
group had to discontinue enteral feeding. However,
because of the small number of patients in this study, fur-
ther studies are required for complete elucidation of these
findings.
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